Table 1 Patient characteristics and clinicopathological features of the 24 gastric tumors used in the study
From: GFRA3 promoter methylation may be associated with decreased postoperative survival in gastric cancer
Number and sex of patients | n = 24 (females n = 7, males n = 17) | |
|---|---|---|
Ethnicity | Caucasian n = 21 Asian n = 3 | |
Age at surgery | Total: 68.4 years (±12.3) | |
Females: 65.4 years (±21.5) | ||
Males: 69.5 years (±8.5) | ||
Postoperative survival (deceased individuals) | 13.3 months (±8.8) | |
Postoperative survival (alive individuals at study end) | 46.0 months (±8.0) | |
Tumor size | 47 mm (±28) | |
Tumor stage | T1 | 3 |
T2 | 13 | |
T3 | 5 | |
T4 | 3 | |
Nodal stage | N0 | 11 |
N1 | 8 | |
N2 | 3 | |
N3 | 2 | |
Histological type | Intestinal | 6 |
Diffuse | 14 | |
Mixed | 4 | |